Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Lupin Australia Pty Limited

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (288)
ARTG (239)
Prescription medicine registration (18)

Date

2024 (48)
2023 (47)
2022 (222)
2021 (8)
2020 (33)
2019 (21)
2018 (32)
2017 (11)
2016 (10)
2014 (27)
2013 (17)
2012 (2)
2011 (16)
2010 (19)
2009 (1)
2008 (21)
2007 (5)
2001 (1)
1991 (4)

Results for "[search-keyword]"

Search

Sponsor content

545 result(s) found, displaying 421 to 430

PERINDOPRIL CH perindopril erbumine 2mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PERINDOPRIL CH perindopril erbumine 4mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PERINDOPRIL CH perindopril erbumine 8mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
SERTRACOR 50 sertraline 50mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
SERTRACOR 100 sertraline 100mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
PERINDOPRIL AND INDAPAMIDE CH 4/1.25 perindopril erbumine 4mg and indapamide hemihydrate1.25mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2018

Cancellation by sponsor

Requested by Lupin Australia Pty Limited
MOXONIDINE LAPL, MOXONIDINE GENERICHEALTH, MOXONIDINE GH (Lupin Australia Pty Limited)

29 June 2018

Prescription medicine registration

Active ingredients: Moxonidine.
TADALAFIL GENERICHEALTH, TADALAFIL LAPL, TADALAFIL GH (Lupin Australia Pty Limited)

25 May 2018

Prescription medicine registration

Active ingredients: Tadalafil.
PREGABALIN LAPL pregabalin 225 mg capsule blister pack (215679)

5 December 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PREGABALIN LAPL pregabalin 225 mg capsule blister pack.
PREGABALIN LAPL pregabalin 150 mg capsule blister pack (215684)

5 December 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PREGABALIN LAPL pregabalin 150 mg capsule blister pack.

Pages

First page
Previous page
…
Page 39
Page 40
Page 41
Page 42
Current page 43
Page 44
Page 45
Page 46
Page 47
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.